Physician profile
Bridget Smart
NPI 1679390470
$2,875.80
in general payments reported to CMS, 2019-2025
35 companies · $2,787 in 2025
The $2,787 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $88.49 · 2025: $2,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,588 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,588.26 |
| Education | $287.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $212.17 | 2025 | Erleada, Rybrevant, Talvey |
| Merck Sharp & Dohme LLC | $191.65 | 2024-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Astellas Pharma US INC | $189.67 | 2025 | Vyloy |
| Lilly USA, LLC | $182.50 | 2025 | Retevmo, Jaypirca, Verzenio |
| Novartis Pharmaceuticals Corporation | $170.63 | 2025 | |
| Eisai INC. | $170.48 | 2025 | |
| Daiichi Sankyo INC. | $162.97 | 2025 | Enhertu, Datroway, Vanflyta |
| Pfizer INC. | $159.91 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $158.10 | 2025 | Imfinzi, Calquence |
| Celgene Corporation | $104.23 | 2025 | Reblozyl |
| Servier Pharmaceuticals LLC | $101.14 | 2025 | |
| Genzyme Corporation | $98.15 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $83.91 | 2025 | Libtayo |
| Pharmaessentia USA Corporation | $77.68 | 2025 | Besremi |
| Emd Serono, INC. | $76.57 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $73.24 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $72.86 | 2025 | Opdualag, Opdivo |
| Genentech USA, INC. | $72.21 | 2024-2025 | Venclexta, Itovebi, Phesgo |
| Tersera Therapeutics LLC | $54.80 | 2025 | Zoladex |
| Gilead Sciences, INC. | $51.25 | 2025 | Trodelvy |
| Ipsen Biopharmaceuticals, INC | $43.94 | 2025 | Onivyde, Somatuline Depot |
| Agios Pharmaceuticals, INC. | $43.26 | 2025 | Pyrukynd |
| Recordati_rare_diseases_inc. | $38.58 | 2025 | Enjaymo |
| Array Biopharma INC | $37.02 | 2025 | Tukysa, Braftovi, Mektovi |
| Kyowa Kirin, INC. | $29.35 | 2024 | Poteligeo |
| Immunocore Limited | $27.72 | 2025 | Kimmtrak |
| Takeda Pharmaceuticals U.S.A., INC. | $27.02 | 2025 | Fruzaqla |
| Exelixis INC. | $25.78 | 2025 | Cabometyx |
| Beone Medicines USA, INC. | $24.98 | 2025 | Brukinsa |
| Geron Corporation | $23.66 | 2025 | Rytelo |
| Alexion Pharmaceuticals, INC. | $21.43 | 2025 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $19.88 | 2025 | |
| Dendreon Pharmaceuticals LLC | $18.34 | 2025 | Provenge |
| Puma Biotechnology, INC. | $16.34 | 2025 | |
| Incyte Corporation | $14.38 | 2025 | Jakafi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Smart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.